News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Eckelman Brendan P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 39,600 shares
@ $24.2007, valued at
$958.3k
Sold 400 shares
@ $24.7075, valued at
$9.9k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 22,213 shares
@ $23.412, valued at
$520.1k
Sold 8,598 shares
@ $24.3575, valued at
$209.4k
Sold 2,084 shares
@ $25.0927, valued at
$52.3k
Sold 4,102 shares
@ $23.1072, valued at
$94.8k
Sold 3,003 shares
@ $23.9903, valued at
$72k
Granted 40,000 options to buy
@ $23.3, valued at
$932k
|
|
| 12/07/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 20,927 shares
@ $26.8348, valued at
$561.6k
Sold 17,681 shares
@ $27.5716, valued at
$487.5k
Sold 1,392 shares
@ $28.4608, valued at
$39.6k
|
|
| 11/02/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 27,651 shares
@ $33.335, valued at
$921.7k
Sold 12,349 shares
@ $33.9008, valued at
$418.6k
|
|
| 10/05/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 1,448 shares
@ $24.6688, valued at
$35.7k
Sold 6,207 shares
@ $26.0614, valued at
$161.8k
Sold 11,136 shares
@ $26.7764, valued at
$298.2k
Sold 4,262 shares
@ $27.7566, valued at
$118.3k
Sold 5,954 shares
@ $28.9713, valued at
$172.5k
Sold 10,893 shares
@ $29.6798, valued at
$323.3k
Sold 100 shares
@ $30.52, valued at
$3.1k
|
|
| 09/14/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 160,000 shares
@ $0
Gifted 80,000 shares
@ $0
Gifted 80,000 shares
@ $0 |
|
| 09/07/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 37,507 shares
@ $14.857, valued at
$557.2k
Sold 2,493 shares
@ $15.6567, valued at
$39k
|
|
| 08/04/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 24,500 shares
@ $17.699, valued at
$433.6k
Sold 15,500 shares
@ $18.4651, valued at
$286.2k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 400 shares
@ $25.04, valued at
$10k
|
|
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 17,000 shares
@ $25.9, valued at
$440.3k
|
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2020 |
3
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 3 on Inhibrx, Inc. |
|
|